1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MINERALYS THERAPEUTICS INC
Mineralys Therapeutics Inc XNAS: MLYS

Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

Read More
47.30 0.19 (0.40%)
New 52W High in past week
1.3M
XNAS Volume

XNAS 12 Nov, 2025 3:15 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Mineralys Therapeutics Inc is on 13 Nov 2025 for the purpose of Stifel Healthcare Conference See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
2.3 / 100
Momentum Score
Technically Bullish
79.9 / 100
Analyst Price Target
No estimates available

16

S

6

W

1

O

3

T

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..